Home Biosimilar Antibodies Others Others antibody Siplizumab (Anti-CD2) For research use only.
Not for use in humans.

Siplizumab (Anti-CD2)

Synonyms: MEDI-507

Siplizumab (Anti-CD2) is a humanized IgG1 monoclonal antibody targeting CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells. MW:145.5 KD.

Siplizumab (Anti-CD2)

Purity & Quality Control

Batch: A256201 Purity: 99% Protein concentration: 12.45mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Siplizumab (Anti-CD2) is a humanized IgG1 monoclonal antibody targeting CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells. MW:145.5 KD.

Product Details

CAS No. 288392-69-8
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Siplizumab (Anti-CD2) | Siplizumab (Anti-CD2) supplier | purchase Siplizumab (Anti-CD2) | Siplizumab (Anti-CD2) cost | Siplizumab (Anti-CD2) manufacturer | order Siplizumab (Anti-CD2) | Siplizumab (Anti-CD2) distributor